Syndromes of ketosis-prone diabetes mellitus

Endocrine Reviews

Volumn 29, Issue 3, 2008, Pages 292-302

  Balasubramanyam, Ashok ^a,b   Nalini, Ramaswami ^a,b   Hampe, Christiane S ^c   Maldonado, Mario ^a,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADOLESCENT; ADULT; AUTOIMMUNITY; CASE REPORT; CELL FUNCTION; DIABETES MELLITUS; FEMALE; GENOTYPE; GLYCEMIC CONTROL; HUMAN; KETOACIDOSIS; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; SYNDROME;

EID: 43549084384     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2007-0026     Document Type: Review

References (54)

1. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark A, Balasubramanyam A 2003 Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88:5090-5098
2. Balasubramanyam A, Garza G, Rodriguez L, Hampe CS, Gaur L, Lernmark A, Maldonado MR 2006 Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care 29:2575-2579
3. Dodu SR 1967 Diabetes in the tropics. Br Med J 2:747-750
4. Adadevoh BK 1968 "Temporary diabetes" in adult Nigerians. Trans R Soc Trop Med Hyg 62:528-530
5. Oli JM 1978 Remittent diabetes mellitus in Nigeria. Trop Geogr Med 30:57-62
6. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP 1987 Maturity-onset diabetes of youth in black Americans. N Engl J Med 316:285-291
7. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE 1994 GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 43:741-745
8. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS 1995 Diabetic ketoacidosis in obese African-Americans. Diabetes 44:790-795
9. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, Nepom GT, Clark WS, Mixon PS, Kitabchi AE 1999 Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 22:1517-1523
10. Aizawa T, Katakura M, Taguchi N, Kobayashi H, Aoyagi E, Hashizume K, Yoshizawa K 1995 Ketoacidosis-onset noninsulin dependent diabetes in Japanese subjects. Am J Med Sci 310:198-201
11. Wilson C, Krakoff J, Gohdes D 1997 Ketoacidosis in Apache Indians with non-insulin-dependent diabetes mellitus. Arch Intern Med 157:2098-2100
12. Pinhas-Hamiel O, Dolan LM, Zeitler PS 1997 Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 20:484-486
13. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V 1999 New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 159:2317-2322
14. Westphal SA 1996 The occurrence of diabetic ketoacidosis in noninsulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med 101:19-24
15. Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P 2001 Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care 24:1014-1018
16. Pitteloud N, Philippe J 2000 Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up. Schweiz Med Wochenschr 130:576-582
17. Jabbar A, Farooqui K, Habib A, Islam N, Haque N, Akhter J 2004 Clinical characteristics and outcomes of diabetic ketoacidosis in Pakistani adults with type 2 diabetes mellitus. Diabet Med 21:920-923
18. Tan KC, Mackay IR, Zimmet PZ, Hawkins BR, Lam KS 2000 Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care 23:335-338
19. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF 2002 Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. Diabetes Metab 28:5-12
20. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, Charpentier G, Guillausseau PJ, Vexiau P, Gautier JF 2004 Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of β-cell dysfunction and insulin resistance. Diabetes 53:645-653
21. Ramos-Roman MA, Pinero-Pilona A, Adams-Huet B, Raskin P 2006 Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes duration. J Diabetes Complications 20:137-144
22. Maldonado M, D'Amico S, Otiniano M, Balasubramanyam A, Rodriguez L, Cuevas E 2005 Predictors of glycaemic control in indigent patients presenting with diabetic ketoacidosis. Diabetes Obes Metab 7:282-289
23. Maldonado MR, Otiniano ME, Cheema F, Rodriguez L, Balasubramanyam A 2005 Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved β-cell function. Diabet Med 22:1744-1750
24. Banerji MA, Dham S 2007 A comparison of classification schemes for ketosis-prone diabetes. Nat Clin Pract Endocrinol Metab 3:506-507
25. Umpierrez GE 2006 Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care 29:2755-2757
26. Umpierrez GE, Smiley D, Kitabchi AE 2006 Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 144:350-357
27. Nalini R, Gaur L, Maldonado M, Hampe C, Rodriguez L, Garza G, Lernmark A, Balasubramanyam A 3 March 2008 HLA class II alleles specify phenotypes of ketosis-prone diabetes (KPD). Diabetes Care 10.2337/dc07-1971
28. Hampe CS, Nalini R, Maldonado MR, Hall TR, Garza G, Iyer D, Balasubramanyam A 2007 Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with β-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus. J Clin Endocrinol Metab 92:462-467
29. Pinero-Pilona A, Raskin P 2001 Idiopathic type 1 diabetes. J Diabetes Complications 15:328-335
30. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR 1993 Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362
31. Pietropaolo M, Barinas-Mitchell E, Pietropaolo SL, Kuller LH, Trucco M 2000 Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes 49:32-38
32. Groop L, Groop PH, Koskimies S 1986 Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 29:757-760
33. Naik RG, Palmer JP 2003 Latent autoimmune diabetes in adults (LADA). Rev Endocr Metab Disord 4:233-241
34. Kobayashi T 1994 Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM-the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 24 Suppl: S95-S99
35. Zhang Z, Apse K, Pang J, Stanton RC 2000 High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 275:40042-40047
36. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC 2007 The cation efflux transporter ZnT8 (Slc30A8) is a major auto-antigen in human type 1 diabetes. Proc Natl Acad Sci USA 104: 17040-17045
37. Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK 2000 High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care 23:838-844
38. Borg H, Gottsater A, Fernlund P, Sundkvist G 2002 A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754-1762
39. Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ 1992 Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41:548-551
40. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohme G 2002 Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 51:1346-1355
41. Umpierrez GE, Smiley D, Gosmanov A, Thomason D 2007 Ketosis-prone type 2 diabetes: effect of hyperglycemia on β-cell function and skeletal muscle insulin signaling. Endocr Pract 13:283-290
42. Sobngwi E, Gautier JF, Kevorkian JP, Villette JM, Riveline JP, Zhang S, Vexiau P, Leal SM, Vaisse C, Mauvais-Jarvis F 2005 High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism pre-disposing to ketosis-prone diabetes. J Clin Endocrinol Metab 90: 4446-4451
43. Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M, Riveline JP, Rajan AS, Kevorkian JP, Zhang S, Vexiau P, German MS, Vaisse C 2004 PAX4 gene variations pre-dispose to ketosis-prone diabetes. Hum Mol Genet 13:3151-3159
44. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM 2001 Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131-153
45. Sobngwi E, Vexiau P, Levy V, Lepage V, Mauvais-Jarvis F, Leblanc H, Mbanya JC, Gautier JF 2002 Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med 19:832-835
46. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R 2007 Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30:2181-2186
47. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA 2006 Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29:2739-2748
48. Hsin Y, Guo H, Wu T 2001 Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients. Diabet Med 18:895-899
49. Rasouli N, Elbein SC 2004 Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab 89:6331-6335
50. Otiniano ME, Balasubramanyam A, Maldonado M 2005 Presence of the metabolic syndrome distinguishes patients with ketosisprone diabetes who have a type 2 diabetic phenotype. J Diabetes Complications 19:313-318
51. Maldonado MR, Chong ER, Oehl MA, Balasubramanyam A 2003 Economic impact of diabetic ketoacidosis in a multiethnic indigent population: analysis of costs based on the precipitating cause. Diabetes Care 26:1265-1269
52. Javor KA, Kotsanos JG, McDonald RC, Baron AD, Kesterson JG, Tierney WM 1997 Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care 20: 349-354
53. Maldonado MR, D'Amico S, Rodriguez L, Iyer D, Balasubramanyam A 2003 Improved outcomes in indigent patients with ketosis-prone diabetes: effect of a dedicated diabetes treatment unit. Endocr Pract 9:26-32
54. Levetan CS, Passaro MD, Jablonski KA, Ratner RE 1999 Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care 22:1790-1795